We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tiziana Life Sciences Plc | LSE:TILS | London | Ordinary Share | GB00BKWNZY55 | ORD 3P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 58.50 | 45.00 | 60.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
15/2/2018 08:08 | I don’t know Jpuff. All I can think of is I heard a report saying about the stockmarket crash, is that investors were getting out of the more riskier stocks. As the market recovers I would expect Tils to recover. Happened on the Brexit referendum, Tils plunged but did recover. Afterall nothing seems to have changed within the company and they have more money and the trials seem to be going as planned. An update on the foralumab trial would be good as the broker note states foralumab is heading to be a blockbuster. | stenick | |
14/2/2018 17:45 | In which case why has the share price taken such a hammering for no apparent reason? | jpuff | |
14/2/2018 07:59 | hxxps://www.beaufort Yes it reads rather well. | stenick | |
13/2/2018 19:02 | And Beaufort's had issued a buy note when 200-220p with a 400p target I seem to recall. | jpuff | |
12/2/2018 13:36 | This decline is as unwarranted as it is bad. I saw this one double and is now back below my buy in price without me selling :(. I do wish they would stop the placings though as they seem to have one every few months. I am keeping the faith here but you need to be a true believer given the share price performance. | mach100 | |
12/2/2018 10:38 | Need some good news now. Marketing license for Milciclib would be nice, or news that trial is still having good results. | stenick | |
06/2/2018 22:24 | Cheers, we know the company shares are very illiquid and move on small sales and buys, so I don't read too much personally into this. | jpuff | |
06/2/2018 21:41 | SORRY for hitting the panic button. Now reads as 10000 shares, £11200 | osammyboy2 | |
06/2/2018 20:45 | That's 11,200 I assume ;) | jpuff | |
06/2/2018 16:23 | Big drop in share price over the last few days.Is there bad news coming? Large sell off book this morning 11,200,000 @ 112p | osammyboy2 | |
06/2/2018 12:05 | bloody OPPs! | rovi70 | |
22/1/2018 07:42 | £100k @£150 DC | daicaprice | |
16/1/2018 18:19 | I don't drink so that's not a lot of good to me lol | osammyboy2 | |
16/1/2018 12:01 | Placing for 150 grand, should buy a round of drinks eh. | jpuff | |
12/1/2018 16:36 | Thanks Stenick. Good to have some optimism. | asmodeus | |
12/1/2018 10:11 | The FDA and EMA have already given Milciclib orphan drug designation, all is needed is proof of efficacy and tolerability and need,to get a marketing licence. I think they have proved that it has all three. From figures on Tils website about numbers of thymus cancers per year I have done a quick calculation of the potential size of market and it’s about £4.5 billion a year. They also have promising phase 1 results in other cancers. So in my opinion we should have some news shortly that is a game changer. Also a Chinese company is buying a major share in the Italian company that discovered Milciclib, Tils has the marketing rights, so China may well want Milciclib as well. As always DYOR. Good luck all. | stenick | |
18/12/2017 17:23 | Right the spread is 4.9 to 5. | stenick | |
18/12/2017 15:00 | 5 Billion's over the top; not a penny over 4.9 in my opinion. | asmodeus | |
18/12/2017 09:37 | Good news, they have money to progress trials. I reckon the next news will be that milciclib will pass the regulators and be put on sale, or a bid for the company will occur and be sold for £5 billion. All my own opinions, I know nothing. | stenick | |
13/12/2017 16:59 | All news is bad news it would seem given the share price reaction. I'm just glad the cryptos are doing so well in the "real world" lol | jpuff | |
11/12/2017 22:14 | Jpuff - you must be an early starter if 0700 is after hours! | supernumerary | |
08/12/2017 08:54 | Excellent news, interested to hear that the existing drug for HCC is only 3% effective and for only 2/3months. Some have been taking Milciclib for upto 5years. A no brainer! | stenick | |
28/11/2017 12:31 | Fast track FDA will only take 2months. | stenick |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions